These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 17274759)

  • 21. Epitope heterogeneity of thyroid-stimulating antibodies predicts long-term outcome in Graves' patients treated with antithyroid drugs.
    Kim TY; Park YJ; Park DJ; Chung HK; Kim WB; Kohn LD; Cho BY
    J Clin Endocrinol Metab; 2003 Jan; 88(1):117-24. PubMed ID: 12519839
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Two Graves' disease patients who spontaneously developed hypothyroidism after antithyroid drug treatment: characteristics of epitopes for thyrotropin receptor antibodies.
    Chung HK; Kim WB; Park DJ; Kohn LD; Tahara K; Cho BY
    Thyroid; 1999 Apr; 9(4):393-9. PubMed ID: 10319947
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Similar effects of thionamide drugs and perchlorate on thyroid-stimulating immunoglobulins in Graves' disease: evidence against an immunosuppressive action of thionamide drugs.
    Wenzel KW; Lente JR
    J Clin Endocrinol Metab; 1984 Jan; 58(1):62-9. PubMed ID: 6196375
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Antibodies to glutamic acid decarboxylase in patients with Graves disease].
    An Z; Zhao H; Li S; Zhao G
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Jan; 34(1):98-9. PubMed ID: 15600194
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The mechanism of spontaneous hypothyroidism in patients with Graves' disease after antithyroid drug treatment.
    Tamai H; Hirota Y; Kasagi K; Matsubayashi S; Kuma K; Iida Y; Konishi J; Okimura MC; Walter RM; Kumagai LF
    J Clin Endocrinol Metab; 1987 Apr; 64(4):718-22. PubMed ID: 2434520
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Graves disease in children: thyroid-stimulating hormone receptor antibodies as remission markers.
    Gastaldi R; Poggi E; Mussa A; Weber G; Vigone MC; Salerno M; Delvecchio M; Peroni E; Pistorio A; Corrias A
    J Pediatr; 2014 May; 164(5):1189-1194.e1. PubMed ID: 24518168
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thyroid histology of hyperthyroid Graves' disease with undetectable thyrotropin receptor antibodies.
    Kawai K; Tamai H; Mori T; Morita T; Matsubayashi S; Katayama S; Kuma K; Kumagai LF
    J Clin Endocrinol Metab; 1993 Sep; 77(3):716-9. PubMed ID: 7690362
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Antibodies against TSH receptors (TRAb) as indicators in prognosing the effectiveness of Tiamazol therapy for Grave's Disease].
    Bojarska-Szmygin A; Ciechanek R
    Wiad Lek; 2003; 56(7-8):303-7. PubMed ID: 14969154
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epitopes for thyroid-stimulating antibodies in Graves' sera: a possible link of heterogeneity to differences in response to antithyroid drug treatment.
    Kim WB; Cho BY; Park HY; Lee HK; Kohn LD; Tahara K; Koh CS
    J Clin Endocrinol Metab; 1996 May; 81(5):1758-67. PubMed ID: 8626830
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Graves' disease].
    Endo T
    Nihon Rinsho; 2006 May; Suppl 1():235-8. PubMed ID: 16776134
    [No Abstract]   [Full Text] [Related]  

  • 31. High prevalence of antineutrophil cytoplasmic antibody positivity in childhood onset Graves' disease treated with propylthiouracil.
    Sato H; Hattori M; Fujieda M; Sugihara S; Inomata H; Hoshi M; Miyamoto S
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4270-3. PubMed ID: 11095466
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Correlation between serum antithyroid antibody titer and changes in thyroid function during therapy of Graves' disease with antithyroid drugs].
    Gao Y; Kong WL; Gao YM
    Zhonghua Nei Ke Za Zhi; 1987 Feb; 26(2):86-9, 125. PubMed ID: 2440645
    [No Abstract]   [Full Text] [Related]  

  • 33. Development of spontaneous hypothyroidism in patients with Graves' disease treated with antithyroidal drugs: clinical, immunological, and histological findings in 26 patients.
    Tamai H; Kasagi K; Takaichi Y; Takamatsu J; Komaki G; Matsubayashi S; Konishi J; Kuma K; Kumagai LF; Nagataki S
    J Clin Endocrinol Metab; 1989 Jul; 69(1):49-53. PubMed ID: 2471711
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The evolution of the ophthalmopathy during antithyroid drug therapy and its relationship with serum thyroglobulin and antithyroglobulin antibody in patients with Basedow's disease.
    Bromberg N; Werner RS; Sgarbi JA; Werner MC; Romaldini JH
    Exp Clin Endocrinol; 1991 May; 97(2-3):354-7. PubMed ID: 1717300
    [No Abstract]   [Full Text] [Related]  

  • 35. Serum IL-18 levels are not increased in patients with untreated Graves' ophthalmopathy.
    Wakelkamp IM; Prummel MF; Wiersinga WM
    Horm Metab Res; 2004 Jan; 36(1):44-7. PubMed ID: 14983406
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Graves' disease].
    Izumi Y; Amino N
    Ryoikibetsu Shokogun Shirizu; 2000; (31):92-5. PubMed ID: 11269198
    [No Abstract]   [Full Text] [Related]  

  • 37. Measurement of stimulating TSH receptor antibodies in sera of patients with Graves' disease by a recombinant TSH receptor bioassay.
    Derwahl M; Schatz H; Bolle B; Pohl A; Meyer K
    Exp Clin Endocrinol; 1992; 100(1-2):75-9. PubMed ID: 1361452
    [No Abstract]   [Full Text] [Related]  

  • 38. [Increased levels of auto-antibodies in thyroid diagnostics: Hashimoto thyroidities or Graves disease?].
    Paschke R
    Internist (Berl); 2006 Nov; 47(11):1193-4. PubMed ID: 17043781
    [No Abstract]   [Full Text] [Related]  

  • 39. Change of circulating thyroid autoantibody titers in Graves' hyperthyroidism after antithyroid drugs therapy.
    Lin HD; Tai FT; Chen HD; Lee SP; Chang FY; Wang GG; Tang KT; Lee JK
    Zhonghua Yi Xue Za Zhi (Taipei); 1991 Feb; 47(2):86-90. PubMed ID: 1705860
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnosis and discrimination of autoimmune Graves' disease and Hashimoto's disease using thyroid-stimulating hormone receptor-containing recombinant proteoliposomes.
    Fukushima H; Matsuo H; Imamura K; Morino K; Okumura K; Tsumoto K; Yoshimura T
    J Biosci Bioeng; 2009 Dec; 108(6):551-6. PubMed ID: 19914592
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.